Objective: Numerous studies have shown associations between the FOX03A gene, encoding the forkhead box 03 transcription factor, and human or specifically male longevity. However, the associations of specific FOX03A polymorphisms with longevity remain inconclusive. We performed a meta-analysis of existing studies to clarify these potential associations. Methods: A comprehensive search was conducted to identify studies of FOX03A gene polymorphisms and longevity. Pooled odds ratios (ORs) and 95% confidence intervals (Cls) were calculated by comparing the minor and major alleles. Results: A total of seven articles reporting associations of FOX03A polymorphisms with longevity were identified and included in this meta-analysis. These comprised 11 independent studies with 5241 cases and 5724 controls from different ethnic groups. rs2802292, rs2764264, rsI3217795, rs1935949 and rs2802288 polymorphisms were associated with human longevity (OR =1.36, 95% CI, 1. 10-1.69, P=0.005; OR =1.20, 95% CI, 1.04-1.37, P=0.01; OR =1.27, 95% CI, 1.10-1.46, P=0.001; OR =1.14, 95% CI, 1.01-1.27 and OR =1.24, 95% CI, 1.07-1.43, P=0.003, respectively). Analysis is stratified by gender indicated significant associations between rs2802292, rs2764264 and rs13217795 and male longevity (OR =1.54, 95% CI, 1.33-1.79, P<0.001; OR =1.38, 95% CI, 1.15-1.66, P=0.001; and OR =1.39, 95% CI, 1.15-1.67, P=0.001), but rs2802292, rs2764264 and rs1935949 were not linked to female longevity. Moreover, our study showed no association between rs2153960, rs7762395 or rs13220810 polymorphisms and longevity. Conclusions: In conclusion, this meta-analysis indicates a significant association of five FOX03A gene polymorphisms with longevity, with the effects of rs2802292 and rs2764264 being male-specific. Further investigations are required to confirm these findings. Objective: To develop Tet-regulated small hairpin RNA (shRNA) that inhibits the malignant phenotypes of tumor cell through Ribonucleic acid interference (RNAi). Methods: Here we build a type of tetracycline (Tet)-inducible vectors which can achieve regulatable expression of shRNA in a time-dependent manner by using synthetic biology approach. In order to prove the effectiveness of this device, we chose hTERT and Bcl-2 as target genes and test the utility of the device on 5637 and T24 cell lines.
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Results:
The experiments show that the Tet-inducible small hairpin RNA can effectively suppress their target genes and generate anti-cancer effects on both 5637 and T24 cell lines. The device we build not only can inhibit proliferation but also can induce apoptosis and suppress migration of the bladder cancer cell lines 5637 and T24. Conclusions: The Tet-inducible small hairpin RNAs may provide a novel strategy for the treatment of human bladder cancer in the future. Objective: ETS-1, one of the members of the ETS gene family, is an important transcription factor that plays key role in the regulation of physiological processes in normal cells and in tumors. In this study, we aimed to investigate the relationship between the transcription factor ETS-1 and malignant phenotypes of bladder cancer. Methods: The expression pattern of ETS-1 was determined in bladder cancer tissues using qRT-PCR. Vectors expressing ETS-1 shRNA and ETS-1 protein were constructed in vitro and transfected into the human bladder cancer T24 and 5637 cells. Results: ETS-1 was up-regulated in human bladder cancer tissue compared to paired normal bladder tissue. Our results showed that the transcription factor ETS-1 could promote cell migration and cell invasion in human bladder cancer, without affecting cell proliferation and immortalization. Conclusions: ETS-1 plays oncogenic roles through inducing cell migration and invasion in human bladder cancer, and it can be used as a therapeutic target for treating human bladder cancer. Objective: To compare the clinical effects and surgical complications of different urinary diversion in the patients who underwent radical cystectomy. Methods: Retrospective analysis clinical data, surgical complications of short and long-term of 21 patients with radical cystectomy (11 with orthotopic sigmoid neobladder, 2 with orthotopic ileal neobladder, 6 with ureterocutaneostomy and 2 with sigma rectum pouch) in our hospital during the past 10 years. Results: Follow up had been made in 6-120 months, and all patients recovered smoothly and there was no tumor recurrence. After 6 month of the operation, no hydronephrosis was found in all cases. There were no significant differences in operation time, median blood loss and hospitalization between orthotopic sigmoid neobladder group and orthotopic ileal neobladder group (P>0.05). And there were significant difference in operation time, median
